Lista de obras - Manuel Rodríguez-Perálvarez

A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.

artículo científico publicado en 2012

AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression

artículo científico publicado en 2016

Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma

scientific article published on 13 February 2020

An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation.

artículo científico publicado en 2017

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

artículo científico

Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.

artículo científico

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

artículo científico publicado en 2018

Controlling Diabetes After Liver Transplantation: Room for Improvement

artículo científico publicado en 2016

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation

artículo científico publicado en 2015

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation.

artículo científico publicado en 2015

Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome

artículo científico publicado en 2012

Everolimus is safe within the first month after liver transplantation.

artículo científico publicado en 2015

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

scientific article published on 01 August 2018

GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner.

artículo científico publicado en 2015

How much immunosuppression is needed after liver transplantation?

scientific article published on 13 September 2013

Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation

scientific article published on 01 December 2018

Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality

artículo científico publicado en 2016

Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact

artículo científico publicado en 2017

Increased incidence of Covid-19 among liver transplant patients in Europe

artículo científico publicado en 2020

Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria

artículo científico publicado en 2014

Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy

artículo científico publicado en 2015

Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation

artículo científico publicado en 2019

Letter: unknown denominator and misleading conclusions in COVID-19

artículo científico publicado en 2020

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.

artículo científico publicado en 2017

Modulating immunosuppression in liver transplant patients with COVID-19

scientific article published on 18 August 2020

Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.

artículo científico publicado en 2015

Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.

artículo científico publicado en 2017

Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis

artículo científico publicado en 2015

Post-colonoscopy colorectal cancer: Characteristics and predictive factors

artículo científico publicado en 2017

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group

artículo científico publicado en 2017

Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count

artículo científico publicado en 2012

Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era

artículo científico publicado en 2018

Radio induced cancer risk during ERCP: Is it a real clinical problem? ⬇️

artículo científico publicado el 1 de abril de 2011

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.

artículo científico publicado en 2017

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.

artículo científico publicado en 2013

Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.

artículo científico publicado en 2013

Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy

artículo científico publicado en 2012

Rescue of Discarded Grafts for Liver Transplantation by Ex Vivo Subnormothermic and Normothermic Oxygenated Machine Perfusion: First Experience in Spain

scientific article published on 14 January 2019

Role of serum cytokine profile in ulcerative colitis assessment

artículo científico publicado en 2012

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells.

artículo científico publicado en 2015

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation

artículo científico publicado en 2015

Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long.

artículo científico publicado en 2013

Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.

artículo científico

Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma

artículo científico publicado en 2013

Use of Peritoneovenous Shunt for the Management of Refractory Ascites

scientific article published on 30 June 2018

[Endoscopic extraction of a foreign body in the sigmoid colon]

artículo científico publicado en 2013

[Esophageal perforation following a biopsy in a patient with eosinophilic esophagitis]

scientific article published on 23 June 2011

[Fulminant ischemic gastropathy: the final stage of a difficult-to-diagnose disease]

scientific article published on 03 November 2010

mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence

artículo científico publicado en 2019

Lista de obras de Manuel Rodríguez-Perálvarez

A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.

AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression

Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma

An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation.

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.

Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Controlling Diabetes After Liver Transplantation: Room for Improvement

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation.

Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome

Everolimus is safe within the first month after liver transplantation.

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

GCDCA down-regulates gene expression by increasing Sp1 binding to the NOS-3 promoter in an oxidative stress dependent manner.

How much immunosuppression is needed after liver transplantation?

Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality

Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact

Increased incidence of Covid-19 among liver transplant patients in Europe

Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria

Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy

Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation

Letter: unknown denominator and misleading conclusions in COVID-19

Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.

Modulating immunosuppression in liver transplant patients with COVID-19

Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.

Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.

Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis

Post-colonoscopy colorectal cancer: Characteristics and predictive factors

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group

Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count

Pretransplant predictors of early mortality in adult recipients of liver transplantation in the MELD-Na Era

Radio induced cancer risk during ERCP: Is it a real clinical problem? ⬇️

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.

Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.

Reducing early exposure to calcineurin inhibitors: the key factor for a successful renal sparing strategy

Rescue of Discarded Grafts for Liver Transplantation by Ex Vivo Subnormothermic and Normothermic Oxygenated Machine Perfusion: First Experience in Spain

Role of serum cytokine profile in ulcerative colitis assessment

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells.

Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation

Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long.

Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.

Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma

Use of Peritoneovenous Shunt for the Management of Refractory Ascites

[Endoscopic extraction of a foreign body in the sigmoid colon]

[Esophageal perforation following a biopsy in a patient with eosinophilic esophagitis]

[Fulminant ischemic gastropathy: the final stage of a difficult-to-diagnose disease]

mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence